Blood test could spare brain tumor patients from repeated surgeries
NCT ID NCT05133154
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates whether a simple blood test can help diagnose and monitor low-grade gliomas, a type of slow-growing brain tumor. Researchers will collect blood samples from 50 patients undergoing brain surgery to look for circulating tumor cells and other markers. The goal is to find a non-invasive way to track tumor growth and detect changes without repeated biopsies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test to help diagnose and monitor low-grade gliomas without repeated surgeries.
- What could go wrong
- This is an early exploratory study with only 50 participants. It may not find reliable blood markers, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital, Montpellier
Montpellier, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Could cutting a wider margin around brain tumors extend survival?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can adding lenvatinib to standard care outsmart a tough brain cancer?
- Can a 7-Week brain tumor treatment beat the standard 10-Week plan?
- Can a sharper beam of radiation shield the mind during brain tumor treatment?